In human NAFLD, CD44 expression in immune cells has been reported to play a key role in NASH37 and here we have shown that CD44+ macrophages are acquired in NAFLD patients developing HCC. Here, CD44 is linked to metabolic dysfunction-associated steatotic liver disease.